India issues draft bioequivalence request format for drugs aimed for export

SINGAPORE--A uniform format by India's Central Drugs Standard Control Organization (CDSCO) to file requests for bioequivalence studies in India on drugs manufactured for export put into a draft for comment.

The draft covers study requests for: New molecules approved in other countries but not India; drugs approved in India within one year; drugs approved in India in a period of one to four years; drugs in modified release form irrespective of their approval status; and so-called old drugs approved in India for more than four years. The deadline for comments is Jan. 25, 2015.

- view the draft (PDF)

Suggested Articles

That didn’t take long. Sanofi CEO Paul Hudson has only been at the reins for a couple months, but on Tuesday, he unveiled a major shakeup.  

New "gold standard" data could further increase doctors' confidence in multiple myeloma med Darzalex, Johnson & Johnson says.

Could Monday's cancer buyout be a hint about what Sanofi CEO Paul Hudson will unveil at Tuesday's investor confab? Analysts think so.